Aviso Wealth Management Sells 79 Shares of The Clorox Company (NYSE:CLX)

Aviso Wealth Management lessened its holdings in shares of The Clorox Company (NYSE:CLX) by 3.5% in the third quarter, HoldingsChannel.com reports. The firm owned 2,151 shares of the company’s stock after selling 79 shares during the period. Aviso Wealth Management’s holdings in Clorox were worth $350,000 as of its most recent SEC filing.

A number of other hedge funds have also recently bought and sold shares of the company. Mitsubishi UFJ Trust & Banking Corp boosted its holdings in shares of Clorox by 24.3% in the 1st quarter. Mitsubishi UFJ Trust & Banking Corp now owns 181,772 shares of the company’s stock worth $27,711,000 after buying an additional 35,477 shares during the last quarter. Vanguard Group Inc. boosted its holdings in shares of Clorox by 0.3% in the 1st quarter. Vanguard Group Inc. now owns 15,277,580 shares of the company’s stock worth $2,339,150,000 after buying an additional 48,632 shares during the last quarter. Davis R M Inc. purchased a new position in shares of Clorox in the 1st quarter worth about $211,000. Trustmark National Bank Trust Department lifted its holdings in Clorox by 12.6% during the first quarter. Trustmark National Bank Trust Department now owns 1,605 shares of the company’s stock valued at $246,000 after purchasing an additional 179 shares during the last quarter. Finally, O Shaughnessy Asset Management LLC lifted its holdings in Clorox by 10.5% during the first quarter. O Shaughnessy Asset Management LLC now owns 20,829 shares of the company’s stock valued at $3,189,000 after purchasing an additional 1,980 shares during the last quarter. 78.53% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other news, EVP Angela C. Hilt sold 1,733 shares of the stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total transaction of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. This represents a 11.40 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Insiders own 0.57% of the company’s stock.

Analysts Set New Price Targets

CLX has been the topic of several recent research reports. Evercore ISI dropped their price objective on shares of Clorox from $140.00 to $139.00 and set an “underperform” rating on the stock in a report on Monday, October 14th. Citigroup upped their price target on Clorox from $165.00 to $170.00 and gave the company a “neutral” rating in a research report on Friday, September 6th. DA Davidson upped their price target on Clorox from $153.00 to $171.00 and gave the company a “neutral” rating in a research report on Monday, November 4th. Barclays upped their price target on Clorox from $137.00 to $139.00 and gave the company an “underweight” rating in a research report on Friday, November 1st. Finally, Jefferies Financial Group upgraded Clorox from a “hold” rating to a “buy” rating and upped their price target for the company from $174.00 to $187.00 in a research report on Tuesday, October 1st. Five equities research analysts have rated the stock with a sell rating, ten have assigned a hold rating and one has issued a buy rating to the stock. Based on data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus price target of $155.00.

Clorox Stock Up 1.1 %

Shares of CLX opened at $167.64 on Monday. The firm has a market cap of $20.75 billion, a P/E ratio of 58.41, a P/E/G ratio of 3.10 and a beta of 0.41. The stock has a 50 day simple moving average of $162.45 and a two-hundred day simple moving average of $147.52. The company has a debt-to-equity ratio of 11.08, a current ratio of 1.00 and a quick ratio of 0.62. The Clorox Company has a 1 year low of $127.60 and a 1 year high of $169.09.

Clorox (NYSE:CLX) last released its quarterly earnings data on Wednesday, October 30th. The company reported $1.86 earnings per share for the quarter, beating analysts’ consensus estimates of $1.36 by $0.50. The firm had revenue of $1.76 billion during the quarter, compared to analyst estimates of $1.64 billion. Clorox had a return on equity of 316.08% and a net margin of 4.78%. The business’s quarterly revenue was up 27.0% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.49 earnings per share. On average, analysts forecast that The Clorox Company will post 6.85 earnings per share for the current fiscal year.

Clorox Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd were paid a dividend of $1.22 per share. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.91%. The ex-dividend date of this dividend was Wednesday, October 23rd. Clorox’s dividend payout ratio (DPR) is presently 170.03%.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.